Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$21.46 USD
-0.42 (-1.92%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $21.48 +0.02 (0.09%) 4:50 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.38 |
EPS Last Quarter | -1.31 |
Last EPS Surprise | -8.26% |
ABR | 1.52 |
Earnings ESP
|
-0.11% |
---|---|
Current Year | -5.46 |
Next Year | -5.47 |
EPS (TTM) | -5.21 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.46M | 10.55M | 55.91M | 85.54M |
# of Estimates | 9 | 9 | 13 | 12 |
High Estimate | 14.39M | 29.52M | 98.51M | 210.00M |
Low Estimate | 4.00M | 2.60M | 35.89M | 9.00M |
Year ago Sales | 11.99M | -1.92M | 36.28M | 55.91M |
Year over Year Growth Est. | -29.47% | 649.32% | 54.14% | 52.98% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.38 | -1.44 | -5.46 | -5.47 |
# of Estimates | 13 | 12 | 14 | 14 |
Most Recent Consensus | -1.40 | -1.60 | -5.64 | -6.22 |
High Estimate | -1.06 | -1.12 | -4.82 | -4.40 |
Low Estimate | -1.53 | -1.69 | -5.75 | -6.45 |
Year ago EPS | -1.38 | -1.46 | -5.42 | -5.46 |
Year over Year Growth Est. | 0.00% | 1.37% | -0.74% | -0.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 5 | 3 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 7 | 9 | 13 | 10 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.38 | -1.44 | -5.46 | -5.47 |
7 Days Ago | -1.38 | -1.44 | -5.46 | -5.47 |
30 Days Ago | -1.38 | -1.44 | -5.44 | -5.46 |
60 Days Ago | -1.32 | -1.36 | -5.08 | -5.26 |
90 Days Ago | -1.32 | -1.36 | -5.08 | -5.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.38 | -1.60 | -5.65 | -6.16 |
Zacks Consensus Estimate | -1.38 | -1.44 | -5.46 | -5.47 |
Earnings ESP | -0.11% | -10.98% | -3.48% | -12.55% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.31 | -1.06 | -1.46 | -1.38 | NA |
Estimate | -1.21 | -1.35 | -1.47 | -1.52 | NA |
Difference | -0.10 | 0.29 | 0.01 | 0.14 | 0.09 |
Surprise | -8.26% | 21.48% | 0.68% | 9.21% | 5.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more